Conversations in Drug Development

Science Podcasts

Welcome to Conversations in Drug Development, brought to you by the team at Boyds for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development. This podcast series features candid...

Episodes

UK Clinical Trial Regulation: What Sponsors Need to Know About UK CTR 2025

How Will the EU Biotech Act Transform Biotechnology Regulation in Europe?

Navigating the FDA Landscape: More Changes, and What's Next?

At the forefront of innovation: Prof Alan Boyd reflects on the last 20 years in drug development

Navigating the New FDA Landscape: Opportunities and Challenges Ahead

From Lab to Launch – Avoiding the Pitfalls of Drug Development

Crystal Ball Gazing: What Does the Future Hold for Regulatory Affairs in Drug Development for 2025

How to Effectively De-Risk your IND Process

Understanding EU Medical Device Regulations: Key Insights for Developers and Innovators

Patients as Partners: Advocacy's Role in Shaping Drug Development

Navigating the Future of EU Health Technology Assessments

A Guide to Marketing Authorisation Applications in Europe

Navigating the new EU Clinical Trials Regulation

Advances in Cell-Based Immunotherapies: CAR-T Cell Therapy vs TCR Therapy

Demystifying Regulatory Designations in Drug Development

Exploring Genome Editing Technologies in Drug Development

The Most Essential Tips for Biotechs Seeking Investment

The Use of ATMPs in Oncology Clinical Trials

How are GMO Regulations Impacting Clinical Development in Europe?

US Drug Development: The Latest Regulatory Trends and Initiatives